{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-066384","form_type":"8-K","ticker":"WOOF","cik":"0001826470","company_name":"Petco Health & Wellness Company, Inc.","filed_at":"2024-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.771403+00:00","generated_at":"2026-06-04T22:29:43.826266+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Petco Q4 GAAP loss $0.08/sh, adjusted EPS $0.02; CEO Coughlin out, Mohan interim","bullets":["Q4 net revenue $1.7B (+6.1% YoY); comparable sales -0.9%; GAAP net loss $22.6M vs prior-year net income $32.7M.","Full-year GAAP net loss $1.3B (incl. $1.2B goodwill impairment); adjusted EPS $0.09 vs $0.61 prior year.","CEO Ron Coughlin stepped down; Board reduced to 10; R. Michael Mohan appointed interim CEO effective March 13.","Mohan compensation: base $1.1M, target bonus 125%, equity awards $8M with exercise price $5.00.","Coughlin to provide transition services through May 1, then consulting at $107,500/month for 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-066384","json":"https://secwatch.observer/filing/0001193125-24-066384.json","markdown":"https://secwatch.observer/filing/0001193125-24-066384.md","text":"https://secwatch.observer/filing/0001193125-24-066384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826470/000119312524066384/0001193125-24-066384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826470/000119312524066384/d812696d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:29:43.826266+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"627fbc4766e5092b937c8e59b33dea451b5ad561","claim":"Petco Health & Wellness Company, Inc. reported fourth quarter and full year 2023 results: revenue $1.7 billion, net income GAAP net loss of $22.6 million or $(0.08) per share, EPS $(0.08) per share.","evidence_excerpt":"FOR IMMEDIATE RELEASE: March 13, 2024 Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2023 Earnings Q4 2023 Highlights • Net revenue of $1.7 billion increased 6.1 percent year over year including the 14 th week • Comparable sales declined 0.9 percent year over year and increased 4.4 percent on a two-year basis • GAAP net loss","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826470/000119312524066384/0001193125-24-066384-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year 2023"},{"label":"Revenue","value":"$1.7 billion"},{"label":"Net income","value":"GAAP net loss of $22.6 million or $(0.08) per share"},{"label":"EPS","value":"$(0.08) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"a36f89ef34","claim":"Ronald V. Coughlin, Jr. departed as Chief Executive Officer, Chairman and member of the Board at Petco Health & Wellness Company, Inc..","evidence_excerpt":"Ronald V. Coughlin, Jr., whose role as the Company’s Chief Executive Officer, Chairman and member of the Board ended effective March 12, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826470/000119312524066384/0001193125-24-066384-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ended"},{"label":"Role","value":"Chief Executive Officer, Chairman and member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}